Care4Asthma

Eligible participants

You may be eligible to participate as a patient if you:

• Are between 5 and 16 years of age.
• Have been diagnosed with asthma requiring regular treatment with an inhaled corticosteroid (with or without a long-acting bronchodilator) delivered by a metered-dose inhaler.
• Have partly controlled or uncontrolled asthma based on GINA criteria and definition.
• Have a parent or legal guardian who is willing to provide written informed consent (and, for children agend ≥10 years, the child’s assent).
  

Your child may be eligible to participate as a non-asthmatic control if they:

• Are between 5 and 16 years of age.
• Have not been diagnosed with asthma.
• Have a blood test foreseen in their medical routine follow up for a non-respiratory disease (e.g. CAKUT, congenital lung malformations, drug allergies, endocrine disorders).
• Have a parent or legal guardian who is willing to provide written informed consent (and, where applicable, the child’s assent).

Exclusion criteria

Your child may not be eligible to participate as a patient if they:

• Do not meet the age requirement.
• Have had a severe asthma attack requiring treatment with oral or injectable corticosteroids within the past 2 weeks or currently have a respiratory infection.
• Have another chronic lung disease, such as BPCO, cystic fibrosis, or similar.
• Have severe asthma.
• Have a serious underlying medical condition or a weakened immune system.
• Are receiving immunotherapy (for participants in Luxembourg taking part in the biomarker research component of the study).
• Have a neurological condition or cognitive impairment that would make participation difficult.
• Have a brother or sister who is already participating in the study.

Your child may not be eligible to participate as a non-asthmatic control if they:

• Do not meet the age requirement.
• Have a confirmed diagnosis of asthma or respiratory or food allergy.
• Have a respiratory tract infection.
• Have another chronic lung disease, such as cystic fibrosis.
• Have a serious underlying medical condition or a weakened immune system.
• Are receiving immunotherapy (for participants in Luxembourg taking part in the biomarker research component of the study) or anti-epileptic treatment.
• Patients with underlying pro-inflammatory disorder (e.g., obesity, chronic inflammatory bowel disease)
• Have a neurological condition or cognitive impairment that would make participation difficult.
• Have a brother or sister who is already participating in the study.

Not sure about eligibility?

The study team will review each case individually to determine eligibility. If you are unsure whether you are eligible, do not hesitate to contact us.